Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
TDP1 protein | 4 | 0 | 0 | 4 |
Smad3 | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 3 | 0 | 0 | 3 |
G | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
IDH1 | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
geminin | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 2 | 3 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 4 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
GLS protein | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Glutamate receptor 1 | 1 | 0 | 0 | 3 |
Glutamate receptor 2 | 2 | 0 | 0 | 4 |
Glutamate receptor 3 | 1 | 0 | 0 | 3 |
Glutamate receptor 4 | 1 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Nicotinamide phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 8 | 0 | 1 | 1 | 2 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 1 | 2 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Glucagon-like peptide 1 receptor | 0 | 0 | 1 | 1 |
Glucagon-like peptide 1 receptor | 0 | 1 | 1 | 2 |
Glucagon receptor | 0 | 0 | 1 | 1 |
Glucagon receptor | 0 | 0 | 1 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
AR protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 1 | 0 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
estrogen-related nuclear receptor alpha | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |